Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 9,800 shares at $30.46 ($299K) on 2016-12-27, disclosed to the SEC on 2016-12-29.
Open-market sale of $299k ACAD by EVP AND GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2017-10-06 | $1.5M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |